ELCC 2015 News: ‘Real-World’ EGFR Mutation Frequency Results From a Large Population of Chemotherapy Naive Patients With Advanced NSCLC By Ogkologos - April 16, 2015 370 0 Facebook Twitter Google+ Pinterest WhatsApp Final results from the IGNITE study Source RELATED ARTICLESMORE FROM AUTHOR ESMO’s Special Consultative Status with United Nations Economic and Social Council (UN ECOSOC) Confirmed Until 2028 EMA Recommends Extension of Indications for Selumetinib ESMO Calls for Urgent Changes to the in Vitro Diagnostic Medical Devices Regulation (IVDR) in Order to Safeguard Cancer Research in Europe MOST POPULAR Mom Fighting Breast Cancer Says Her Haunted House Is Something To... October 30, 2019 FDA Approves Ivosidenib for Advanced or Metastatic Cholangiocarcinoma August 30, 2021 FDA Approves Trastuzumab Deruxtecan for Any HER2-Positive Solid Cancer May 3, 2024 New Safety Signal for Use of Ibrutinib in Combination with Rituximab... September 15, 2021 Load more HOT NEWS UK Clinical Trial Compares E-cigarettes, Nicotine-Replacement Products for Smoking Cessation What Happens If More People Get Screened for Cancer? 74 & 75-Year-Old Sweethearts Get Married In ICU In Wake Of... FDA Approves Selpercatinib for Locally Advanced or Metastatic RET Fusion-Positive NSCLC
